Marieke Verhagen, MD

PhD student, MD
Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands. Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Nijmegen, the Netherlands. Laboratory of hematology, Radboud university medical center, Nijmegen, the Netherlands

Marieke Verhagen is a PhD student at the department of Hematology and laboratory of Hematology of the Radboud university medical center. Currently, she is working on the sixth Hemophilia in the Netherlands study (HiN6-study). With her project she focusses on thrombin and plasmin generation and low-titer inhibitors in patients with hemophilia.

Presentation(s):

• PB0563 - The ultra-sensitive Nijmegen Inhibitor Assay detects very low-titer factor VIII inhibitors.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 63.1 - Decreased thrombin generation profile is associated with severe bleeding phenotype in hemophilia: data from the Hemophilia in the Netherlands study

  Tuesday, July 12, 2022
  2:45 PM – 3:00 PM